What is he best known for?
The fields of study he is best known for:
Craig A. Harrison mostly deals with Internal medicine, Endocrinology, Cell biology, Signal transduction and Myostatin.
The study incorporates disciplines such as Endothelial stem cell and Bone morphogenetic protein 15 in addition to Internal medicine.
He studies Endocrinology, focusing on Lipopolysaccharide in particular.
The Signal transduction study which covers Growth differentiation factor that intersects with Protein structure and Signal peptide.
His research in Myostatin intersects with topics in Protein kinase B, PI3K/AKT/mTOR pathway and Bone morphogenetic protein 7.
His Activin type 2 receptors study incorporates themes from Activin receptor, Cripto, ACVR1 and Follistatin.
His most cited work include:
- Antagonists of activin signaling: mechanisms and potential biological applications (246 citations)
- Antagonists of activin signaling: mechanisms and potential biological applications (246 citations)
- Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis (165 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Endocrinology, Cell biology, Receptor and Signal transduction.
His work deals with themes such as Biological activity and Bone morphogenetic protein, which intersect with Internal medicine.
The Activin type 2 receptors, Sertoli cell and TGF beta signaling pathway research Craig A. Harrison does as part of his general Endocrinology study is frequently linked to other disciplines of science, such as Growth differentiation factor-9, therefore creating a link between diverse domains of science.
His Cell biology study integrates concerns from other disciplines, such as Growth differentiation factor and Myostatin.
His biological study deals with issues like Binding site, which deal with fields such as Mutant, Peptide sequence and Inhibin binding.
His Signal transduction study combines topics in areas such as Cripto and Structure–activity relationship.
He most often published in these fields:
- Internal medicine (89.36%)
- Endocrinology (88.65%)
- Cell biology (46.81%)
What were the highlights of his more recent work (between 2018-2021)?
- Endocrinology (88.65%)
- Internal medicine (89.36%)
- Cancer research (13.48%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Endocrinology, Internal medicine, Cancer research, Receptor and Bone morphogenetic protein 15.
His biological study spans a wide range of topics, including Mutation and Mutagenesis.
He combines subjects such as Andrology and Binding site with his study of Internal medicine.
He has researched Receptor in several fields, including Signal transduction, Cell biology and Bone morphogenetic protein.
He is studying Transforming growth factor, which is a component of Cell biology.
In his work, Cachexia, Muscle hypertrophy and Myostatin is strongly intertwined with Muscle atrophy, which is a subfield of Follistatin.
Between 2018 and 2021, his most popular works were:
- Therapeutic blockade of activin-A improves NK cell function and antitumor immunity (20 citations)
- Cumulin and FSH cooperate to regulate inhibin B and activin B production by human granulosa-lutein cells in vitro (6 citations)
- Activin A-Induced Cachectic Wasting Is Attenuated by Systemic Delivery of Its Cognate Propeptide in Male Mice. (5 citations)
In his most recent research, the most cited papers focused on:
Craig A. Harrison spends much of his time researching Internal medicine, Endocrinology, Growth differentiation factor-9, Bone morphogenetic protein 15 and Atrophy.
His study of Growth differentiation factor-9 brings together topics like Granulosa cell, Granulosa Lutein Cell, INHBB, Ovarian follicle and Polycystic ovary.
His Andrology research extends to Bone morphogenetic protein 15, which is thematically connected.
Craig A. Harrison interconnects Muscle hypertrophy, Myostatin, Skeletal muscle, Cachexia and Wasting in the investigation of issues within Atrophy.
His Wasting research integrates issues from Systemic administration and Protein degradation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
